HCW Biologics Inc. (HCWB) Stock

HCW Biologics Inc. (HCWB) is a Healthcare stock trading at $2.18 (as of 2026-08-21), with a market capitalization of $2.45M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Understand HCW Biologics Inc.: how it makes money

HCW Biologics Inc. operates in pharmaceutical products, but the provided information does not specify the exact products it sells or the specific revenue streams it uses.

The company shows exceptionally high reported margins (gross margin 100%, operating margin 50%), yet it is graded Unprofitable, which makes the profit model look potentially non-repeatable or driven by reporting and scale rather than steady operations.

Business quality (Unprofitable): Business quality grade: Unprofitable.

Bull case

  • Very strong gross economics: The company reports gross margin 100%, which suggests favorable economics at the gross level (before operating expenses).
  • Operating costs appear controlled: With operating margin 50%, the company converts gross economics into meaningful operating profitability, indicating operating expenses are not overwhelming the gross profit.

Bear case

  • Margins conflict with unprofitable grade: Despite reporting operating margin 50%, the provided business-quality assessment is Unprofitable, raising concerns about earnings quality or whether the margins reflect a durable operating business.
Valuation — source: SEC EDGAR (first-party)
Price$2.18
Market Cap$2.45M
Price / Book0.42
Price / Sales0.37
FCF Yield-831.6%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$54232.00
Net Margin-14677.1%
Revenue Growth (YoY)-97.9%
EPS Growth (YoY)1280.5%
FCF Growth (YoY)-7.6%
Financial Health — source: SEC EDGAR
Altman Z-Score-8.48 (distress)
Piotroski F-Score3/9 (weak)
Valuation vs Sector & Industry
Sector P/E (Healthcare)21.7
Industry P/E (Pharmaceutical Products)17.2
Company
SectorHealthcare
IndustryPharmaceutical Products

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • GRI Bio, Inc. (GRI)
  • Genprex, Inc. (GNPX)
  • Artelo Biosciences, Inc. (ARTL)
  • 60 Degrees Pharmaceuticals, Inc. (SXTP)
  • Ernexa Therapeutics Inc. (ERNA)
  • Nexentis Technologies Inc. (NXTS)
  • Onconetix, Inc. (ONCO)
  • Oragenics, Inc. (OGEN)
HCWB earnings history · HCWB institutional & insider holders · HCWB KPIs & operating metrics · HCWB financials · HCWB investor presentations & press releases · HCWB SEC filings · HCWB peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-08-21.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.